PKC412 and 5-Azacytidine

NCT01202877 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: 5-azacytidine
DRUG: PKC412

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]